FDA NDC Directory · JSON-LD · Markdown

Lansoprazole

NDC 0378-6982 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Generic namelansoprazole
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202396
Dosage form / routeTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (30 mg/1)
Marketing started20181129
Package count1

External sources

Source: openFDA. Public-domain (CC0).